Literature DB >> 26740892

Seasonal Association of Immune Thrombocytopenia in Adults.

Anıl Tombak1, Burcu Boztepe2, Naci Tiftik1, Melda Cömert3, Ozan Salim4, Kaniye Aydın5, Emel Gürkan6, Orhan Kemal Yücel4, Güray Saydam3, Mehmet Ali Sungur7.   

Abstract

BACKGROUND: Immune thrombocytopenia (ITP) is an autoimmune disorder. It is characterized by thrombocytopenia due to thrombocyte destruction mediated by autoantibodies; however, cytotoxic and defective regulatory T-lymphocytes play an important role in its pathogenesis. While childhood ITP is usually acute, self-limiting and generally seasonal in nature, ITP in adults is usually chronic; its relation with seasons has not been studied. AIMS: We investigated whether months and/or seasons have triggering roles in adults with ITP. STUDY
DESIGN: Descriptive study.
METHODS: A retrospective case review of adult patients with primary ITP diagnosed at various University Hospitals in cities where Mediterranean climate is seen was performed. Demographic data, date of referral and treatments were recorded. Corticosteroid-resistant, chronic and refractory cases were determined. Relation between sex, corticosteroid-resistant, chronic and refractory ITP with the seasons was also investigated.
RESULTS: The study included 165 patients (124 female, mean age=42.8±16.6). Most cases of primary ITP were diagnosed in the spring (p=0.015). Rates of patients diagnosed according to the seasons were as follows: 35.8% in spring, 23% in summer, 20.6% in fall, and 20.6% in winter. With respect to months, the majority of cases occurred in May (18.2%). Time of diagnosis according to the seasons did not differ between genders (p=0.699). First-line treatment was corticosteroids in 97.3%, but 35% of the cases were corticosteroid-resistant. Steroid-resistant patients were mostly diagnosed in the spring (52.1%) (p=0.001). ITP was chronic in 52.7% of the patients and they were also diagnosed mostly in the spring (62.7%) (p=0.149).
CONCLUSION: This is the first study showing seasonal association of ITP in adults and we have observed that ITP in adults is mostly diagnosed in the spring. The reason why more patients are diagnosed in the spring may be due to the existence of atmospheric pollens reaching maximum levels in the spring in places where a Mediterranean climate is seen.

Entities:  

Keywords:  Allergens; immune thrombocytopenia; pollen; seasons

Year:  2015        PMID: 26740892      PMCID: PMC4692332          DOI: 10.5152/balkanmedj.2015.151223

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  32 in total

1.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

Review 2.  Interleukin-9 as a T helper type 17 cytokine.

Authors:  Elizabeth C Nowak; Randolph J Noelle
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

3.  A case-control study to assess the risk of immune thrombocytopenia associated with vaccines.

Authors:  Lamiae Grimaldi-Bensouda; Marc Michel; Elodie Aubrun; Pamela Leighton; Jean-Francois Viallard; Daniel Adoue; Nadine Magy-Bertrand; Guillaume Tisserand; Mehdi Khellaf; Jean-Marc Durand; Philippe Quittet; Olivier Fain; Bernard Bonnotte; Anne Sophie Morin; Nicolas Limal; Nathalie Costedoat-Chalumeau; Nathalie Morel; Brigitte Pan-Petesch; Olivier Decaux; Matthieu Mahevas; Michel Ruel; Karim Sacre; Francois Lefrere; Lucien Abenhaim; Bertrand Godeau
Journal:  Blood       Date:  2012-10-24       Impact factor: 22.113

Review 4.  Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.

Authors:  Alina Isai; Julie Durand; Steven Le Meur; Ana Hidalgo-Simon; Xavier Kurz
Journal:  Vaccine       Date:  2012-09-26       Impact factor: 3.641

Review 5.  Virus-associated idiopathic thrombocytopenic purpura.

Authors:  M L Rand; J F Wright
Journal:  Transfus Sci       Date:  1998-09

Review 6.  The pathologic and clinical intersection of atopic and autoimmune disease.

Authors:  Ankoor Shah
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

7.  The incidence of idiopathic thrombocytopenic purpura in adults increases with age.

Authors:  H Frederiksen; K Schmidt
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

8.  Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease.

Authors:  Bernward Zeller; Jukka Rajantie; Iris Hedlund-Treutiger; Ulf Tedgård; Finn Wesenberg; Olafur G Jonsson; Jan Inge Henter
Journal:  Acta Paediatr       Date:  2005-02       Impact factor: 2.299

9.  T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.

Authors:  Bob Olsson; Per-Ola Andersson; Margareta Jernås; Stefan Jacobsson; Björn Carlsson; Lena M S Carlsson; Hans Wadenvik
Journal:  Nat Med       Date:  2003-08-24       Impact factor: 53.440

Review 10.  Role of regulatory T cells and FOXP3 in human diseases.

Authors:  Rosa Bacchetta; Eleonora Gambineri; Maria-Grazia Roncarolo
Journal:  J Allergy Clin Immunol       Date:  2007-08       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.